ArticleIranian journal of biotechnology2026
Single-Cell and Mendelian Randomization Analyses Identify Macrophage Polarization and Efferocytosis Biomarkers in Osteoarthritis and Reveal Their Regulatory Mechanisms.
Article in Iranian journal of biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoarthritis (OA) is a progressive joint disease influenced by macrophage-associated efferocytosis. Objective: This study aimed to identify key OA biomarkers by integrating transcriptomic and single-cell RNA sequencing (scRNA-seq) data with Mendelian randomization (MR). Materials and Methods: We integrated three OA-related transcriptomic datasets (GSE89408, GSE55457, and GSE152805) from synovial tissue with efferocytosis- and macrophage polarization-related genes (ERGs and MPRGs). Differentially expressed genes (DEGs) were identified and analyzed using gene set enrichment (ssGSEA), weighted gene co-expression network analysis (WGCNA), and functional enrichment (GO/KEGG). MR was performed with GWAS data to evaluate causal links between candidate genes and OA. Machine learning methods (LASSO and SVM-RFE), supported by ROC analysis and artificial neural network (ANN) modeling, and were used to screen potential biomarkers. Single-cell RNA-seq analysis was conducted with Seurat, incorporating clustering, functional enrichment, cell-cell communication (CellChat), and pseudotime trajectory analysis (Monocle) to characterize cellular heterogeneity and differentiation pathways in OA. Results: MR and machine learning highlighted FMO4 and GPR65 as risk biomarkers, validated in independent datasets (AUC > 0.7). GPR65 showed strong associations with neutrophils, regulatory T cells, and antigen-presenting cell (APC) co-inhibition, while both genes were enriched in immune and metabolic pathways. Single-cell analysis identified synovial subintimal fibroblasts and HLA-DRA+ cells as key contributors with distinct differentiation patterns. An ANN model further improved OA classification. Conclusion: These findings provide new insights into OA pathogenesis and support FMO4 and GPR65 as promising diagnostic and therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.